Replies to post #669032 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

We are at the early stage of introducing a new process which has the potential to reduce timelines substantially. We will work with industry stakeholders to develop this process further.

That is under "Established Medicines" (generics and label changes) which has had a huge backlog.

But very possible that could be what MHRA is digging up to answer you.